Ledger.Open graph →
SEC Form D · Amendment · filed July 10, 2019

RELMADA THERAPEUTICS, INC

Offering
$10.0M
Sold
$8.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Danny Lin · SAN MATEO, CADirectorRocco Lavista · Freehold, NJExecKevin Mcallister · BALTIMORE, MDDirectorCorey B. Mulloy · Seattle, WADirectorHoward Davner · Freehold, NJExec · DirectorChristopher Bentley · Spring, TXDirectorMason H. Resch · Chicago, ILDirectorTyler J. Resch · Chicago, ILDirectorJonpaul J. Jonkheer · Chicago, ILExec · DirectorDominic A. Bassani · Old Bethpage, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗